RNS Number : 7354S
SEEEN PLC
17 June 2024
 

17 June 2024

 

SEEEN plc

("SEEEN", the "Group" or the "Company")

 

Result of General Meeting

and

Total Voting Rights

 

SEEEN plc (AIM: SEEN), the media and technology platform that delivers Key Video Moments to drive increased views and revenues across video content, announces the results of the voting on the Resolutions put to its General Meeting held earlier today. All Resolutions put to Shareholders at the meeting were duly passed.

Total Voting Rights

Pursuant to its Fundraise to raise a total of approximately £763,000, details of which were announced on 31 May 2024, the Company has applied for Admission of the Second Fundraise Shares to trading on AIM ("Second Admission"). Second Admission is anticipated to occur at 8.00 a.m. on 19 June 2024.

Following Second Admission, the Company's issued ordinary share capital will consist of 118,779,141 Ordinary Shares with one voting right per Ordinary Share. The Company does not hold any Ordinary Shares in treasury. Therefore, following Second Admission, the total number of Ordinary Shares and voting rights in the Company will be 118,779,141. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company pursuant to the FCA's Disclosure Guidance and Transparency Rules.

Director and significant shareholdings

Following Second Admission, the revised holdings of the Directors who are interested in the Company's Ordinary Shares will be as set out in the table below:

 

Name

Board role

Number of Subscription Shares

Total number of Ordinary Shares held following Second Admission

% of enlarged ordinary share capital following Second Admission

Dr Patrick DeSouza

Non-Executive Chairman

2,000,000

7,426,164*

6.25%*

Adrian Hargrave

Chief Executive Officer

                933,333

1,985,747

1.67%

David Anton

Non-Executive Director

1,333,333

1,333,333

1.12%

Mark Williams

Non-Executive Director

333,333

333,333

0.28%

 

* This includes Ordinary Shares held directly and the interest of a related trust, of which Dr DeSouza's immediate family are the sole beneficiaries. Dr DeSouza is the trustee of the trust.

 

In addition, as a result of the issue of the Second Fundraise Shares, the Company is aware of the following interests of certain significant shareholders (as defined in the AIM Rules for Companies) in the Company, which will be revised following Admission:

 

Name

Number of Ordinary Shares held following Second Admission

Percentage of enlarged share capital following Second Admission

Water Intelligence plc**

5,938,366

5.00%




 

** Dr DeSouza is a director of Water Intelligence plc and Dr DeSouza is interested in 25% of Water Intelligence plc's issued share capital.

 

Capitalised terms used in this announcement shall, unless defined in this announcement or unless the context provides otherwise, bear the same meaning ascribed to such terms in the announcement made by the Company at 07:00 on 31 May 2024.

 

 

For further information please contact:

 

SEEEN, seeen.com

Tel: +44 (0)7775 701 838

Adrian Hargrave, CEO




Dowgate Capital (Joint Broker)

Tel: +44 (0)20 3903 7721

Stephen Norcross




Capital Plus Partners Ltd (Joint Broker)

Tel: +44 (0)203 821 6167

Jonathan Critchley / Jon Levinson




Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: +44 (0)20 3328 5656

Alex Brearley / George Payne / Lauren Wright (Corporate Finance)

Tony Quirke / Amrit Nahal (Sales and Corporate Broking)


 

Focus IR (Investor Relations)

Tel: +44(0)7866 384 707

Paul Cornelius / Kat Perez

seeen@focusir.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGGPUWAQUPCGGM